Metabolomics Market Size & Share, by Product & Services (Instruments, Bioinformatics Tools & Services); Application (Biomarker Discovery, Drug Discovery, Toxicology Testing, Functional Genomics, Personalized Medicine, Nutrigenomics); Indication (Cancer, Cardiovascular Disorders, Neurological Disorders); Techniques (Separation, Detection) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2033

  • Report ID: 515
  • Published Date: Feb 13, 2023
  • Report Format: PDF, PPT

Companies Dominating the Metabolomics Landscape

top-features-companies
    • Thermo Fisher Scientific
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Agilent Technologies
    • Biocrates Life Sciences AG
    • Bio-Rad Laboratories, Inc.
    • Bruker
    • Danaher
    • Human Metabolome Technologies America Inc.
    • LECO Corporation
    • Metabolon, Inc.
    • Shimadzu Corporation

Browse Key Market Insights with Data Illustration:

In-the-news

In The News

  • Thermo Fischer Scientific in association with UC Davis launched a Center of Excellence in Clinical Metabolomics, a research collaboration to provide the metabolomics community with innovations that will develop standardized processes for the research community, optimized liquid chromatography-mass spectrometry (LC-MS) methods to support the rapid scale-up of large cohort studies.

  • Agilent Technologies announced a new range of products designed to increase capabilities for food testing, environmental screening, and metabolomics research to provide enhanced analytical and business outcomes for laboratories.


Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 515
  • Published Date: Feb 13, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Growing acceptance of metabolomics in personalized medicine, increased incidence of chronic diseases, funding from government and private authorities are the major factors driving the growth of the metabolomics market.

The market is anticipated to attain a CAGR of 13% over the forecast period, i.e., 2023-2033.

The complexity increases in interpreting data, the high price of metabolomic instruments, and the scarcity of professionals are the challenges affecting the market growth.

The market in the Asia Pacific region is projected to hold the largest market share by the end of 2033 and provide more business opportunities in the future.

The major players in the market are Agilent Technologies, Biocrates Life Sciences AG, Bio-Rad Laboratories, Inc., Bruker, Danaher, Human Metabolome Technologies America Inc., LECO Corporation, Metabolon, Inc., Shimadzu Corporation., and others.

The company profiles are selected based on the revenues generated from the product segment, and the geographical presence of the company which determines the revenue-generating capacity as well as the new products being launched into the market by the company.

The market is segmented by product & services, application, indication, metabolomics, and by region.

The cancer segment is anticipated to garner the largest market size by the end of 2033 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying